Nello Mainolfi

Companies

• Kymera TherapeuticsBoard member Aug 20, 2020 to now¹
• Kymera TherapeuticsChief executive officer Aug 20, 2020 to now¹
• Kymera TherapeuticsPresident Aug 20, 2020 to Aug 21, 2020¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKymera Therapeutics KYMR666,568 shares²$72.0M at $108.02Jul 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 7, 2026Sold 50,000 shares at $119.00 of Kymera Therapeutics²
• Jul 7, 2026Exercised options 50,000 shares at $2.08 of Kymera Therapeutics²
• Jul 1, 2026Sold 3,336 shares at $116.56 of Kymera Therapeutics³
• Jul 1, 2026Sold 44,050 shares at $115.69 of Kymera Therapeutics³
• Jul 1, 2026Sold 24,105 shares at $114.96 of Kymera Therapeutics³
• Jul 1, 2026Sold 6,626 shares at $113.98 of Kymera Therapeutics³
• Jul 1, 2026Sold 1,883 shares at $112.80 of Kymera Therapeutics³
• Jul 1, 2026Exercised options 80,000 shares at $2.08 of Kymera Therapeutics³
• Apr 29, 2026Sold 936 shares at $82.45 of Kymera Therapeutics⁴
• Apr 29, 2026Sold 12,059 shares at $81.70 of Kymera Therapeutics⁴
• Apr 29, 2026Sold 17,005 shares at $80.74 of Kymera Therapeutics⁴
• Apr 29, 2026Exercised options 30,000 shares at $2.08 of Kymera Therapeutics⁴
• Feb 25, 2026Sold 8 shares at $93.49 of Kymera Therapeutics⁵
• Feb 25, 2026Sold 1,501 shares at $92.81 of Kymera Therapeutics⁵
• Feb 25, 2026Sold 3,293 shares at $91.76 of Kymera Therapeutics⁵
• Feb 25, 2026Sold 5,434 shares at $90.39 of Kymera Therapeutics⁵
• Feb 25, 2026Sold 19,764 shares at $89.78 of Kymera Therapeutics⁵
• Feb 25, 2026Exercised options 30,000 shares at $2.08 of Kymera Therapeutics⁵
• Jan 5, 2026Exercised options 3,118 shares at $32.07 of Kymera Therapeutics⁶
• Dec 31, 2025Sold 6,014 shares at $78.52 of Kymera Therapeutics⁷
• Dec 31, 2025Sold 23,986 shares at $77.95 of Kymera Therapeutics⁷
• Dec 31, 2025Exercised options 30,000 shares at $2.08 of Kymera Therapeutics⁷
• Dec 17, 2025Exercised options 2,595 shares at $38.53 of Kymera Therapeutics⁸
• Dec 8, 2025Sold 100,000 shares at $89.17 of Kymera Therapeutics⁹
• Dec 8, 2025Exercised options 100,000 shares at $2.08 of Kymera Therapeutics⁹